The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA Peptide Reclassification 2026 Amanecia Health GHK Cu: The Peptide That Transforms Skin and Tissue Health Calibrate Hydration January 2026 FDA New Drug Approvals Zycubo (copper histidinate) Some approvals mark progress. Others redefine what hope looks like. In January 2026, the U.S. FDA approved Zycubo (copper histidinate injection formerly FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure